Drugs / CAB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02411435 | Jul → Sep 2015 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02411435 ↗ |
| Action | Inhibit | “oral cabotegravir, an integrase strand transfer inhibitor” PMID 28739783 ↗ Sep 2017 |